Taficita-EM (Descovy)
Introducing Taficita-EM (Descovy) at GetInPrEP: Your Premier Choice for Modern HIV Prevention. Taficita-EM, a cutting-edge PrEP medication, combines the latest in antiretroviral technology with tenofovir alafenamide and emtricitabine, offering superior protection against HIV with a more favorable safety profile than older generations. Ideal for those seeking effective HIV prophylaxis, Taficita-EM minimizes the risk of bone density and kidney-related side effects, setting a new standard in PrEP care.
For more information about Taficita-EM (Descovy), consult your doctor or pharmacist. You can also find information on reputable health websites and in the literature provided by the medication's manufacturer.
Data sheet
- Expire date
- 10/26
- Trademark
- Descovy
- Use
- PrEP
- Active principle
- Emtricitabine / Alafenamide
- Supply Length
- 30 Tablets
- Dosage
- 1 tablet daily
- Presentation
- Film-Coated Tablets
- chevron_left
- 1
- chevron_right
Your review appreciation cannot be sent
Report comment
Report sent
Your report cannot be sent
Write your review
Review sent
Your review cannot be sent